Follow The Filings

UGI

Earnings company data as of 4:48 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by UGI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UGI insider trades
  • None no insider bought on the open market
  • $3.6M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kathleen Shea-Ballay GC and Chief Legal Officer
    Sale
    $852K 25,360 shares at $33.62 100% of stake
    Traded Jun 18 Filed Jun 23
  2. Jean Felix Tematio VP, CAO & Corporate Controller
    Sale
    $489K 12,840 shares at $38.07 65% of stake
    Traded Feb 11 Filed Feb 13
  3. Joseph L. Hartz President of Subsidiary
    Sale
    $192K 5,000 shares at $38.45 13% of stake
    Traded Dec 17, 2025 Filed Dec 18, 2025
  4. Sean O'Brien CFO
    Sale
    $1.1M 28,709 shares at $37.65 100% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  5. Hans G. Bell President of Subsidiary
    Sale
    $440K 11,300 shares at $38.91 38% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
  6. Joseph L. Hartz President of Subsidiary
    Sale
    $580K 15,000 shares at $38.68 31% of stake
    Traded Nov 25, 2025 Filed Nov 28, 2025

Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 9 stock grants, and 5 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 1.01,9.01
8-K 1.01,2.03,9.01
8-K 1.01,2.03,9.01
8-K 5.02,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 1.01,2.03,9.01
8-K 5.02
8-K 1.01,1.02,2.03,8.01,9.01
8-K 1.01,2.03,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 7.01,8.01,9.01
8-K 7.01,8.01,9.01
8-K 8.01,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.